VivoSeq
Other

Orthopedic Surgery

0

Pipeline Programs

2

Active Trials

3

Companies Involved

Orthopedic Surgery is an early-stage landscape with 0 programs across 3 companies. The most active players are Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Purdue Pharma LP, Daiichi Sankyo.

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

11/100

Mech. Concentration

N/A

Completion Rate

83/100

Attrition Rate

14/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

28

clinical trials

Completed19 · 68%
Unknown status3 · 11%
Terminated2 · 7%
Withdrawn2 · 7%
Not yet recruiting1 · 4%
Enrolling by invitation1 · 4%

Trial Activity

28 trials

Post-operative Methylprednisolone Taper Course for Orthopedic Surgery
Enrolling by invitation·EEmory University·Phase 4·NCT03661645·500 enrolled
General Decolonization With Octenisan® Set Before Elective Orthopedic Surgery
Completed··Phase 3·NCT05647252·1,086 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)